+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Interbody Fusion Cage Market by Product, Surgery Type, and End User - Global Opportunity 7Analysis and Industry Forecast, 2017-2023

  • ID: 4603654
  • Report
  • June 2018
  • Region: Global
  • 305 pages
  • Allied Analytics LLP
1 of 4
The global interbody fusion cage market was valued at $1,818 million in 2016, and is expected to reach $2,309 million by 2023 with a CAGR of 3.4% during the forecast period. Interbody fusion cage, also known as spinal cage is an artificial device used in spinal fusion procedures to maintain foraminal height and decompression. The interbody fusion cage is a large, hollow cylinder made up of metals such as titanium, carbon fiber, or allograft femur.

Rise in geriatric population, increase in incidences of spinal injuries and sports injuries, and technological advancements in medical sciences are the key factors that drive the growth of the market. In addition, increased demand for interbody fusion cage surgeries due to advantages that allow the surgeon to directly decompress nerves and reconstruct the spine also fuel the market growth. However, high costs associated with spinal fusion surgeries and increase in disposable incomes in emerging economies are anticipated to restrain the market growth. Further, the introduction of awareness programs regarding the potential benefits of interbody fusion cages and minimally fusion surgeries especially in the developing economies create lucrative opportunities in the market.

The global interbody fusion cage market is segmented based on product, surgery type, end user, and region. Based on product, it is divided into lumbar, cervical, thoraco-lumbar, and thoracic. Based on surgery, it is classified into anterior, posterior, lateral, and transforaminal. Based on end user, it is categorized into hospital, clinic, medical center, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS

The study provides an in-depth analysis of the global interbody fusion cage market with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps to understand the products and technologies used globally.
Key market players and their strategies are provided understand the competitive outlook of the market

KEY MARKET SEGMENTS

By Product

Lumbar
Cervical
Thoraco-lumbar
Thoracic

By Surgery Type

Anterior
Transforaminal
Posterior
Lateral

By End User

Hospital
Clinic
Ambulatory Surgical Center
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
South Africa
Saudi Arabia
Rest of LAMEA

KEY PLAYERS PROFILED

Aurora Spine, Inc.
B. Braun Melsungen AG
Benvenue Medical, Inc.
Ulrich Medicals USA
Prodorth
Orthofix International, N.V.
Medtronic, plc
Zimmer Biomet, Inc.
NuVasive, Inc.,
Johnson & Johnson (DePuy Synthesis)

The OTHER PLAYERS in the value chain include (profiles not included in the report) the following:

Biomet USA
Globus Medical USA
Spineart France
Precision Spine USA
Medacta Switzerland
K2M USA
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porters five forces analysis
3.4. Market share analysis, 2016
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in geriatric population
3.5.1.2. Increase in spinal surgeries
3.5.1.3. Technological advancements in spinal fusion surgeries
3.5.2. Restraints
3.5.2.1. High cost associated with the spinal fusion surgeries
3.5.2.2. Lack of trained professionals
3.5.3. Opportunities
3.5.3.1. Increased adoption of minimally invasive techniques.

CHAPTER 4: INTERBODY FUSION CAGE MARKET, BY PRODUCT
4.1. Overview
4.2. Market size and forecast
4.3. Lumbar
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Cervical
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Thoraco-lumbar
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Thoracic
4.6.1. Key market trends and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country

CHAPTER 5: INTERBODY FUSION CAGE MARKET, BY SURGERY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Anterior
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Transforaminal
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Posterior
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Lateral
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

CHAPTER 6: INTERBODY FUSION CAGE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Clinics
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Ambulatory Surgical Centers
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
6.5. Others
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country

CHAPTER 7: INTERBODY FUSION CAGE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. North America market size and forecast, by country
7.2.2.1. U.S. market size and forecast, by product
7.2.2.2. U.S. market size and forecast, by surgery type
7.2.2.3. U.S. market size and forecast, by end user
7.2.2.4. Canada market size and forecast, by product
7.2.2.5. Canada market size and forecast, by surgery type
7.2.2.6. Canada market size and forecast, by end user
7.2.2.7. Mexico market size and forecast, by product
7.2.2.8. Mexico market size and forecast, by surgery type
7.2.2.9. Mexico market size and forecast, by end user
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by surgery type
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Europe market size and forecast, by country
7.3.2.1. Germany market size and forecast, by product
7.3.2.2. Germany market size and forecast, by surgery type
7.3.2.3. Germany market size and forecast, by end user
7.3.2.4. France market size and forecast, by product
7.3.2.5. France market size and forecast, by surgery type
7.3.2.6. France market size and forecast, by end user
7.3.2.7. U.K. market size and forecast, by product
7.3.2.8. U.K. market size and forecast, by surgery type
7.3.2.9. U.K. market size and forecast, by end user
7.3.2.10. Italy market size and forecast, by product
7.3.2.11. Italy market size and forecast, by surgery type
7.3.2.12. Italy market size and forecast, by end user
7.3.2.13. Spain market size and forecast, by product
7.3.2.14. Spain market size and forecast, by surgery type
7.3.2.15. Spain market size and forecast, by end user
7.3.2.16. Rest of Europe market size and forecast, by product
7.3.2.17. Rest of Europe market size and forecast, by surgery type
7.3.2.18. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by surgery type
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan market size and forecast, by product
7.4.2.2. Japan market size and forecast, by surgery type
7.4.2.3. Japan market size and forecast, by end user
7.4.2.4. China market size and forecast, by product
7.4.2.5. China market size and forecast, by surgery type
7.4.2.6. China market size and forecast, by end user
7.4.2.7. India market size and forecast, by product
7.4.2.8. India market size and forecast, by surgery type
7.4.2.9. India market size and forecast, by end user
7.4.2.10. Australia market size and forecast, by product
7.4.2.11. Australia market size and forecast, by surgery type
7.4.2.12. Australia market size and forecast, by end user
7.4.2.13. Rest of Asia-Pacific market size and forecast, by product
7.4.2.14. Rest of Asia-Pacific market size and forecast, by surgery type
7.4.2.15. Rest of Asia-Pacific market size and forecast, by end user
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by surgery type
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil market size and forecast, by product
7.5.2.2. Brazil market size and forecast, by surgery type
7.5.2.3. Brazil market size and forecast, by end user
7.5.2.4. Turkey market size and forecast, by product
7.5.2.5. Turkey market size and forecast, by surgery type
7.5.2.6. Turkey market size and forecast, by end user
7.5.2.7. South Africa market size and forecast, by product
7.5.2.8. South Africa market size and forecast, by surgery type
7.5.2.9. South Africa market size and forecast, by end user
7.5.2.10. Saudi Arabia market size and forecast, by product
7.5.2.11. Saudi Arabia market size and forecast, by surgery type
7.5.2.12. Saudi Arabia market size and forecast, by end user
7.5.2.13. Rest of LAMEA market size and forecast, by product
7.5.2.14. Rest of LAMEA market size and forecast, by surgery type
7.5.2.15. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by surgery type
7.5.5. LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES
8.1. Aurora Spine, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.2. B. Braun Melsungen AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.3. Benvenue Medical, Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segment
8.3.4. Key strategic moves and developments
8.4. Prodorth
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.5. Ulrich Medical USA
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Key strategic moves and developments
8.6. ORTHOFIX INTERNATIONAL N.V.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segment
8.6.4. Business performance
8.6.5. Key strategic moves and developments
8.7. MEDTRONIC PLC
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key Business Strategy:
8.8. ZIMMER BIOMET HOLDINGS, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segment
8.8.4. Business performance
8.9. NuVasive, Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.10. Johnson & Johnson (DePuy Synthes)
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report, titled, Interbody Fusion Cage Market by Product, Surgery Type and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global interbody fusion cage market was valued at $1,818 million in 2016, and is projected to reach $2,309 million by 2023, growing at a CAGR of 3.4% from 2017 to 2023. The lumbar segment accounted for about two-sevenths share of the global market in 2016.

Interbody fusion cage are medical devices utilized to provide stability to the spine and the cervical region. Interbody fusion cages are large hollow cylinders made of metals and alloys such as carbon fiber, titanium, and allograft femur. The cages can be filled with autologous bone material to promote arthrodesis (artificial induction of joint ossification).

Rise in geriatric population and increase in spil cord injuries which might be caused due to accidents and diseases such as degenerative disk disease drive the growth of the market. However, the high cost associated with the spil fusion surgeries and the dearth of skilled professiols impede the growth of the interbody fusion cage market. Moreover, the increased adoption of minimally invasive surgeries create ample opportunities in the market.

Among the product segment, the cervical segment accounted for about one-fourth share of the total market in 2016. This is due to the increase in cervical fusion surgeries, which helps preserve the motion of the spine without bone grafting. Also, the cervical disc replacement does not require a plate placement directly in the front of the spine.

Among the surgery type segment, the anterior segment accounted for one-third share of the total market owing to the ease in accessing the body from the front section. This results in the increase in anterior interbody fusion surgeries globally.

Key Findings of the Interbody Fusion Cage Market:

The thoraco-lumbar segment accounted for about one-fourth share of the total market in 2016, and is expected to register a high CAGR of 3.5% from 2017 to 2023.
The hospital segment accounted for two-fifths share of the total market and is expected to grow at a CAGR of 3.1% during the forecast period.
U.S. dominated the North America interbody fusion cage market and is projected to retain its trend throughout the forecast period.
India is the fastest growing country in the Asia-Pacific interbody fusion cage market, registering a CAGR of 7.1% during the forecast period.
The ambulatory surgery center segment accounted for one-fourth of the market share in 2016, and is expected to grow at a high CAGR of 3.4%.

In 2016, North America was the dominant revenue contributor, owing to high prevalence rate of spil cord injuries. Also, the increase in geriatric population who are prone to spil injuries and diseases boost the market growth in North America. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to the presence of high populace countries such as India and Chi. In addition increase in awareness regarding interbody fusion cage, and rise in disposable income also fuel the market growth.

The key players operating in the global interbody fusion cage market are Aurora Spine, Inc., B. Braun Melsungen AG, Benvenue Medical, Inc., Ulrich Medicals USA, Prodorth, Orthofix Intertiol, N.V., Medtronic, plc, Zimmer Biomet, Inc., NuVasive, Inc., and Johnson & Johnson (DePuy Synthesis). Other players operating in the value chain are Biomet USA, Globus Medical USA, Spineart France, Precision Spine USA, Medacta Switzerland, and K2M USA.
Note: Product cover images may vary from those shown
5 of 4

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll